MarkWide Research

Sale!

Injectable Cytotoxic Drugs Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: December, 2022
No of Pages: 164
Delivery Format: PDF+ Excel

$2,950.00

Injectable Cytotoxic Drugs Market
1. Injectable Cytotoxic Drugs Market Overview
Injectable Cytotoxic Drugs are medicines used to treat cancer. They work by killing cancer cells or stopping them from growing. Cytotoxic drugs are usually given by injection into a vein.

The global injectable cytotoxic drugs market is expected to grow at a CAGR of around 6.5% during the forecast period of 2020-2025.

The injectable cytotoxic drugs market is segmented by drug type, therapeutic application, and geography. By drug type, the market is classified into alkylating agents, anthracyclines, plant alkaloids, and others. By therapeutic application, the market is classified into breast cancer, leukemia, lung cancer, and others.

The market is further segmented by geography into North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Some of the key players operating in the global injectable cytotoxic drugs market are Pfizer Inc., Johnson & Johnson Services, Inc., Novartis AG, Bayer AG, and Merck & Co., Inc.

2. Injectable Cytotoxic Drugs Market Drivers
The global injectable cytotoxic drugs market is expected to grow at a CAGR of around 6.5% during the forecast period of 2020-2025. The major factors driving the growth of this market are the rising prevalence of cancer, increasing number of product approvals, and the growing demand for targeted therapy.

Cancer is one of the leading causes of death worldwide. According to the World Health Organization (WHO), around one in six deaths globally is due to cancer. The number of cancer cases is expected to rise to 24.6 million by 2035. The rising prevalence of cancer is one of the major factors driving the growth of the injectable cytotoxic drugs market.

The number of product approvals has increased in recent years. In 2018, the US Food and Drug Administration (FDA) approved 48 new cancer drugs, which was the highest number of approvals in a single year. This increasing number of product approvals is expected to boost the growth of the injectable cytotoxic drugs market.

Targeted therapy is a type of cancer treatment that targets specific molecules or genes that are involved in the growth and spread of cancer cells. It is a more precise and effective treatment option than traditional chemotherapy. The growing demand for targeted therapy is expected to drive the growth of the injectable cytotoxic drugs market.

The rising costs of treatment and the side effects associated with injectable cytotoxic drugs are the major factors restraining the growth of this market.

The major players operating in the global injectable cytotoxic drugs market are Pfizer, Inc., Roche Holding AG, Novartis AG, and Merck & Co., Inc.

3. Injectable Cytotoxic Drugs Market Challenges
The global injectable cytotoxic drugs market is expected to reach USD XX billion by 2025 from USD YY billion in 2019, at a CAGR of ZZ%. The market is driven by factors such as the rising incidence of cancer, increasing investment by pharmaceutical companies in cancer research, and the launch of new cytotoxic drugs.

However, the market faces certain challenges that are inhibiting its growth. These include the high cost of treatment, the stringent regulations governing the development and commercialization of cytotoxic drugs, and the side effects associated with these drugs.

1. The high cost of treatment is a major challenge for the growth of the injectable cytotoxic drugs market. Cytotoxic drugs are used to treat various types of cancer, which is a costly disease to treat. The high cost of treatment is a major barrier to the growth of the market.

2. The stringent regulations governing the development and commercialization of cytotoxic drugs are another challenge for the market. These regulations are in place to ensure the safety and efficacy of these drugs. However, they can also delay the development and commercialization of these drugs, which can limit their market growth.

3. The side effects associated with cytotoxic drugs are another challenge for the market. These drugs can cause a number of side effects, such as hair loss, nausea, and vomiting. These side effects can limit the use of these drugs and hinder their market growth.

4. Injectable Cytotoxic Drugs Market Opportunities
Injectable Cytotoxic Drugs Market: Introduction

Injectable cytotoxic drugs are used to treat various types of cancer. Cytotoxic drugs kill cancer cells by damaging their DNA. Injectable cytotoxic drugs are administered directly into the tumor or the blood stream. Injectable cytotoxic drugs are used in the treatment of various types of cancer, including leukemia, lymphoma, and breast cancer.

The global injectable cytotoxic drugs market is anticipated to expand at a significant CAGR during the forecast period. The injectable cytotoxic drugs market is primarily driven by the rising prevalence of cancer and the increasing number of cancer patients. According to the American Cancer Society, the number of cancer cases is expected to reach 23.6 million by 2030. In addition, the rising number of clinical trials for the development of new injectable cytotoxic drugs is anticipated to fuel the growth of the market during the forecast period.

Injectable Cytotoxic Drugs Market: Key Segments

The global injectable cytotoxic drugs market has been classified on the basis of drug type, application, and distribution channel.

On the basis of drug type, the global injectable cytotoxic drugs market has been classified into alkylating agents, plant alkaloids, topoisomerase inhibitors, and others. The alkylating agents segment is anticipated to expand at a significant CAGR during the forecast period. Alkylating agents are the most commonly used injectable cytotoxic drugs. They are used in the treatment of various types of cancer, including leukemia, lymphoma, and breast cancer.

On the basis of application, the global injectable cytotoxic drugs market has been classified into leukemia, lymphoma, breast cancer, and others. The leukemia segment is anticipated to expand at a significant CAGR during the forecast period. Leukemia is a type of cancer that starts in the blood-forming cells of the bone marrow. According to the Leukemia & Lymphoma Society, an estimated 61,780 people were diagnosed with leukemia in the U.S. in 2017.

On the basis of distribution channel

5. Injectable Cytotoxic Drugs Market Size and Forecast
Cancer is one of the leading causes of death worldwide, with an estimated 9.6 million deaths in 2018. Injectable cytotoxic drugs are used in the treatment of cancer. These drugs are designed to kill cancer cells or prevent their growth.

The global injectable cytotoxic drugs market was valued at USD XX million in 2018 and is expected to reach USD XX million by 2026, at a CAGR of XX% during the forecast period.

The increase in the incidence of cancer is the major factor driving the growth of the injectable cytotoxic drugs market. According to the World Health Organization, the global incidence of cancer is expected to increase by about 70% over the next two decades.

The increase in the number of clinical trials and the launch of new products are the major factors driving the growth of the injectable cytotoxic drugs market.

The high cost of treatment is the major factor restraining the growth of the market.

North America is expected to dominate the global injectable cytotoxic drugs market due to the increase in the incidence of cancer and the availability of advanced healthcare infrastructure.

The key players in the injectable cytotoxic drugs market are AstraZeneca, Pfizer, Roche, Sanofi, and Novartis.

This blog is based on the report by MarketsandMarkets titled, “Injectable Cytotoxic Drugs Market by Type (Platinum-Based, Taxanes, Alkylating Agents), Route of Administration (Oral, Intravenous), End User (Hospitals, Specialty Clinics, Cancer Research Institutes), and Geography – Global Forecast to 2026”

The global injectable cytotoxic drugs market is segmented by type, route of administration, end user, and geography.

On the basis of type, the market is segmented into platinum-based, taxanes, alkylating agents, and others. The platinum-based segment is expected to grow at the highest CAGR during the forecast period.

On the basis of route of administration, the market is segmented into intravenous and oral. The intravenous segment

6. Injectable Cytotoxic Drugs Market Trend Analysis
Injectable cytotoxic drugs are used to treat cancer and other serious diseases. They are usually given intravenously (into a vein) or intramuscularly (into a muscle). They are sometimes given intrathecally (into the spinal fluid).

Injectable cytotoxic drugs are very powerful drugs and can have serious side effects. Some of the most common side effects are nausea and vomiting, hair loss, fatigue, and diarrhea. More serious side effects can include low blood counts, organ damage, and secondary cancers.

Injectable cytotoxic drugs are usually given as part of a treatment regimen that includes other cancer treatments, such as surgery, radiation therapy, and/or other chemotherapy drugs.

The use of injectable cytotoxic drugs has increased over the past few years as more and more cancer patients are being treated with these drugs. The trend is expected to continue as more new and more effective injectable cytotoxic drugs are developed.

7. Injectable Cytotoxic Drugs Market Growth Analysis
The global injectable cytotoxic drugs market is expected to grow at a CAGR of around 7% during the forecast period of 2019-2024. The market is driven by the increasing prevalence of cancer and the rising demand for targeted therapies.

Injectable cytotoxic drugs are used to treat a variety of cancers. They work by killing cancer cells or by preventing them from growing and spreading. These drugs are usually given intravenously (into a vein) or intramuscularly (into a muscle).

The increasing prevalence of cancer is the major driver of the injectable cytotoxic drugs market. According to the World Health Organization, the number of new cancer cases is expected to rise by about 70% over the next two decades. The rising incidence of cancer is due to the aging population and the increasing adoption of unhealthy lifestyles.

The rising demand for targeted therapies is another major driver of the injectable cytotoxic drugs market. Targeted therapies are more effective and have fewer side effects than traditional chemotherapy drugs. They work by targeting specific molecules that are involved in the growth and spread of cancer cells.

The high cost of injectable cytotoxic drugs is the major restraint of the market. These drugs are very expensive and are not affordable by all patients. In addition, the side effects of these drugs can be severe, which limits their use.

The market is segmented by drug type, route of administration, and geography. By drug type, the market is divided into alkylating agents, anti-metabolites, plant alkaloids, and others. By route of administration, the market is classified into intravenous and intramuscular.

Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest market for injectable cytotoxic drugs, followed by Europe. The market in Asia Pacific is expected to grow at the highest CAGR during the forecast period.

The major players in the injectable cytotoxic drugs market are Pfizer Inc., Merck & Co., Inc., Roche Holding AG, Novartis AG, and Eli Lilly and

LIST OF KEY COMPANIES PROFILED:

    • Johnson and Johnson Services Inc., (U.S)
    • Sanofi (France)
    • Eli Lilly and Company (U.S)
    • Bristol-Myers Squibb Company (New York, U.S)
    • F. Hoffmann-La Roche Ltd. (Basel, Switzerland)
    • Novartis AG (Basel, Switzerland)
    • Pfizer, Inc (New York, U.S)
    • Merck & Co. Inc (New Jersey, U.S)
    • Amgen (California, U.S.)

Report Scope & Segmentation

 

 ATTRIBUTE

 

 

DETAILS

 

 

Study Period

 

 

2016-2027

 

 

Base Year

 

 

2019

 

 

Forecast Period

 

 

2020-2027

 

 

Historical Period

 

 

2016-2018

 

 

Unit

 

 

Value (USD billion)

 

 

Segmentation

 

 

By Drug Class

    • Alkylating Drugs
    • Cytotoxic Antibodies
    • Antimetabolites
    • Plant Alkaloids
    • Others
 

By Application

    • Oncology
    • Rheumatoid Arthritis
    • Multiple Sclerosis
    • Others
 

By End-user

    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
 

By Geography

    • North America (U.S. and Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
    • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
    • Latin America (Brazil, Mexico, and Rest of Latin America)
    • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
 

By Drug Class

    • Alkylating Drugs
    • Cytotoxic Antibodies
    • Antimetabolites
    • Plant Alkaloids
    • Others
 

By Application

    • Oncology
    • Rheumatoid Arthritis
    • Multiple Sclerosis
    • Others
 

By End-user

    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
    • Johnson and Johnson Services Inc., (U.S)
    • Sanofi (France)
    • Eli Lilly and Company (U.S)
    • Bristol-Myers Squibb Company (New York, U.S)
    • F. Hoffmann-La Roche Ltd. (Basel, Switzerland)
    • Novartis AG (Basel, Switzerland)
    • Pfizer, Inc (New York, U.S)
    • Merck & Co. Inc (New Jersey, U.S)
    • Amgen (California, U.S.)

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF